Objective: To the association between metabolically healthy overweight/obesity and the risk of sudden cardiac death in middle-aged men. Participants and Methods: This prospective study was based on a population sample of 2185 men aged 42 to 60 years from the Kuopio Ischaemic Heart Disease Risk Factor Study. Participants were divided into 4 groups on the basis of body mass index and metabolic health status. Metabolically healthy overweight/ obesity was defined as body mass index 25 kg/m 2 or greater without metabolic abnormalities, and metabolically unhealthy normal weight was defined as body mass index less than 25 kg/m 2 with 1 or more metabolic abnormalities. Results: During a median follow-up of 26 years (interquartile range, 18.7-28.1 years), 240 sudden cardiac deaths (11%) occurred. Compared with metabolically healthy normal weight men, metabolically unhealthy overweight/obese men had a higher risk of sudden cardiac death (hazard ratio, 1.99; 95% CI, 1.03-3.85) after adjusting for potential confounders. However, metabolically healthy overweight/obese men were not at increased risk of sudden cardiac death (hazard ratio, 0.95; 95% CI, 0.40-2.24) as compared with their metabolically healthy normal weight counterparts after adjusting for age, smoking, low-density lipoprotein cholesterol level, high-sensitivity C-reactive protein level, insulin level, history of myocardial infarction, and directly measured peak oxygen uptake. Conclusion: Our findings indicate that metabolically healthy normal weight men and metabolically healthy overweight/obese men were at comparable risk of sudden cardiac death over a 26-year follow-up period, suggesting that a baseline body mass index of 25 kg/m 2 or greater per se does not adversely affect the risk of sudden cardiac death. A lthough metabolically healthy obese (MHO) individuals appear to be at increased risk of coronary heart disease (CHD), cerebrovascular disease, and heart failure than do their metabolically healthy normal weight (MHNW) counterparts, 1 other studies have reported no association between MHO individuals and cardiovascular events.
A lthough metabolically healthy obese (MHO) individuals appear to be at increased risk of coronary heart disease (CHD), cerebrovascular disease, and heart failure than do their metabolically healthy normal weight (MHNW) counterparts, 1 other studies have reported no association between MHO individuals and cardiovascular events. 2, 3 Furthermore, it remains unclear whether differences in body habitus and metabolic health profiles extend to cardiac arrest as a predictable cardiovascular outcome in the general population. Sudden cardiac death (SCD) is a global public health concern, accounting for up to 50% of all cardiovascular deaths. Although obesity has been associated with a higher risk of SCD, the effect of overweight/obesity on the incidence of SCD remains unclear because of inherent confounding variables. 4, 5 To further clarify these potential risk modulators, we examined the association between metabolically healthy overweight/obese middle-aged men and the risk of SCD over an extended follow-up period.
PARTICIPANTS AND METHODS
This prospective investigation included participants from the Kuopio Ischaemic Heart Disease Risk Factor Study, which is a prospective population-based long-term study designed to evaluate risk factors for cardiovascular disease (CVD) and related outcomes in a randomly selected sample of men from eastern Finland. Of the original cohort of 3433 men who resided in the town of Kuopio or its surrounding rural communities, 198 were excluded for various reasons (eg, serious disease or moved from the area). At baseline, examinations were conducted on 2682 men (82.9% of the eligible population) between March 1, 1984 , and December 31, 1989. Participants whose blood markers and anthropometric variables were initially assessed were included in the present analysis (N¼2185; age, 42-60 years). The Kuopio Ischaemic Heart Disease Risk Factor Study was approved by the Committee on Research Ethics of the University of Eastern Finland, and all study participants provided written informed consent.
Body mass index (BMI) was calculated as the weight in kilograms divided by the height meters squared. Our cohort did not include any participants who were underweight (BMI<18.5 kg/m 2 ). Resting blood pressure was measured using a sphygmomanometer and was expressed as the mean value from 6 measurements: 3 while supine, 1 while standing, and 2 while sitting. Blood samples were collected in the morning after a 12-hour overnight fast and analyzed according to standard protocols. Laboratory methods and other assessments are described elsewhere. 6 Peak oxygen uptake as an index of cardiorespiratory fitness was directly measured using a computerized metabolic measurement system during an electrically braked progressive cycle ergometer exercise test to volitional fatigue.
Our study population was divided into 4 groups on the basis of cross-classification of BMI and metabolic health status: MHNW; metabolically unhealthy normal weight (MUNW); metabolically healthy overweight/ obese (MHOO); and metabolically unhealthy overweight/obese (MUOO). We used a hybrid definition of metabolically healthy obesity with a modified BMI (original BMI cutoff was !30 kg/m 2 ) as previously suggested. 7 Being MHOO was defined as a BMI of 25 kg/m 2 or greater with zero or no metabolic abnormalities or risk factors as signified by the following: systolic blood pressure 130 mm Hg or greater or diastolic blood pressure 85 mm Hg or greater or antihypertensive drug treatment; highdensity lipoprotein cholesterol level less than 40 mg/dL (<1.0 mmol/L); serum triglyceride level 150 mg/dL or greater (!1.7 mmol/L) or treatment of hypertriglyceridemia; and fasting blood glucose level 100 mg/dL or greater (!5.6 mmol/L) or treatment with hypoglycemic agents. We excluded waist circumference from the definition of metabolically healthy obesity, because most participants met the criteria for a high waist circumference. 7 Sudden cardiac death was defined as a fatal event that occurred within 1 hour of the onset of symptoms or within 24 hours when autopsy data did not reveal a noncardiac cause of SCD or after a fatal cardiac arrest after successful resuscitation from ventricular tachycardia and/or ventricular fibrillation. The diagnostic classification of events was based on symptoms, electrocardiographic (ECG) findings, cardiac enzyme elevations, autopsy findings (80% of the SCDs), and history of CHD combined with relevant clinical and ECG findings. Data on SCDs were derived from interviews with family members, hospital records, death certificates, autopsy reports, and medicolegal documents. A detailed definition of SCD has been previously described. 6 We calculated the hazard ratio (HR) and 95% CI using the multivariable Cox proportional hazards model with adjustment for confounding variables to determine the relations of body phenotypes (ie, normal weight and overweight/obese) to the risk of SCD. For multivariable analysis, potential confounding variables (ie, covariates) were selected as variables with statistically significant differences among groups, as shown in Table 1 . Statistical significance was set at P less than .05, and analyses were conducted using SPSS version 21.0 (IBM Corp.). Table 1 summarizes the baseline characteristics of the study participants grouped by metabolic health status and body habitus. We found that 193 of the 2185 participants (8.8%) were classified as MHOO. There were significant differences in age, BMI, smoking, history of myocardial infarction, prevalence of diabetes and hypertension, resting systolic and diastolic blood pressures, lipid and lipoprotein profiles, glucose level, insulin level, high-sensitivity C-reactive protein level, and peak oxygen uptake among the 4 groups (P<.05).
RESULTS
During a median follow-up of 26 years (interquartile range, 18.7-28.1 years), 240 SCDs (11%) occurred. Compared with MHNW men, those who were classified as MHOO were not at increased risk of SCD (HR, 0.95; 95% CI, 0.40-2.24) after adjusting for age, smoking, low-density lipoprotein cholesterol level, high-sensitivity C-reactive protein level, insulin level, history of myocardial infarction, and peak oxygen uptake. However, MUOO men had a higher risk of SCD (HR, 1.99; 95% CI, 1.03-3.85) than did their MHNW counterparts ( Table 2 ). The KaplanMeier survival analysis revealed that the survival rate of SCD in the MHOO cohort was similar to that in the MHNW cohort (Figure) .
DISCUSSION
Although obesity is associated with an increased risk of SCD 3 and selected risk factors may predispose obese men to an increased risk of SCD, it appears that these and other risk factors operate differently in patients with and without preexisting ischemic heart disease. 5 Thus, the effect of obesity on incident SCD remains unclear because of potential confounding variables and/or substantial unexplained variance. Over a 26-year follow-up period, we found that men who were MHOO were not at increased risk of SCD than their MHNW counterparts. Our results are consistent with previous reports 2, 3, 8 and further extend the effect of metabolically healthy overweight/obese on SCD risk as counterintuitively related to "healthy or unhealthy overweight/obese." 9 To our knowledge, this is the first long-term study to report that MHOO men were not at increased risk of SCD than their MHNW peers. However, additional studies are needed to confirm these results. In contrast, the largest prospective study to date found that over a 5.4-year follow-up period, MHO individuals were at increased risk of CHD, cerebrovascular disease, and heart failure, but not peripheral vascular disease, as compared with MHNW individuals. 1 Interestingly, a subgroup analysis with a relatively long-term follow-up (>10 years) period reported that MHO individuals were at increased risk of all-cause mortality and CVD events. 2 Another investigation using the strictest definition of metabolic health, that is, no metabolic abnormalities, found no association between MHO individuals and CVD events. 3 However, the analysis had limited statistical power.
We believe that various definitions of metabolic health, body habitus (eg, obesity vs overweight/obesity), follow-up durations, and sex differences may, at least in part, be responsible for the conflicting data in the literature. Furthermore, another reason for these conflicting results may be the inability to account for physical activity or cardiorespiratory fitness as important potential confounding variables. [9] [10] [11] It is interesting to note that those studies that adjusted for cardiorespiratory fitness or physical activity did not find increased risk of CVD mortality in MHO individuals, 12, 13 which is compatible with the present findings. In our 26-year follow-up study, after adjusting for potential confounders, including cardiorespiratory fitness, MHOO men were not at increased risk of SCD as compared with MHNW men.
In reference to the association between body habitus, cardiometabolic risk factors, and the risk of SCD, our results indicated that MUNW men were not at a significantly higher risk of incident SCD than their MHNW counterparts. However, the risk of incident SCD in MUNW men appears to be higher than that in MHNW men. The present findings are consistent with previous studies that reported an increased risk of mortality in MUNW individuals than in MHNW individuals.
14 Accordingly, strategies of prevention/treatment should consider the individual's metabolic health status as an important confounding variable in overweight/obese individuals and in normal weight individuals. However, additional studies are needed to further clarify the relation between metabolically unhealthy nonobese individuals and the risk of SCD.
We acknowledge several methodological limitations. Because our study population included only men, we were unable to determine whether this association extends to women. Although we adjusted for numerous potential confounders, other variables that we did not assess may have influenced these associations. Unfortunately, our database did not include selected ECG variables, specifically QRS duration, QT interval, and Tpeak-Tend interval, as well as heart rate variability and left ventricular ejection fraction, all of which may be related to the incidence of SCD. Inclusion of these parameters in future studies would provide additional mechanistic insights relative to the associated risk modulators. In addition, the total number of SCDs (240 events [11 %]) and study cohorts was relatively small, especially MHNW (n¼232) and MHOO (n¼193 [8.8%] strong potential confounder that is often either estimated or unaccounted for in major metabolically healthy obesityerelated studies, 10,11 was directly measured as peak oxygen uptake.
CONCLUSION
Our results indicate that compared with MHNW men, MUOO men had a higher risk of SCD but MHOO men were not at increased risk of SCD after adjusting for potential confounders, including cardiorespiratory fitness, over a 26-year follow-up period.
Abbreviations and Acronyms: BMI = body mass index; CHD = coronary heart disease; CVD = cardiovascular disease; ECG = electrocardiographic; HR = hazard ratio; MHNW = metabolically healthy normal weight; MHO = metabolically healthy obese; MHOO = metabolically healthy overweight/obese; MUNW = metabolically unhealthy normal weight; MUOO = metabolically unhealthy overweight/obese; SCD = sudden cardiac death
